Trials / Completed
CompletedNCT06415045
A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food
The Effect of Food on the Pharmacokinetics of BI 1015550 (Formulation C2) Following Single Oral Dose Administration in Healthy Subjects (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Design)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The main objective is to investigate the effect of food on the pharmacokinetics of BI 1015550 Formulation C2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 1015550 | Participants received a single 18 mg Nerandomilast Formulation C2 film-coated tablet either after an overnight fast of at least 10 hours or following a high-fat, high-calorie meal. |
Timeline
- Start date
- 2024-05-28
- Primary completion
- 2024-07-24
- Completion
- 2024-07-24
- First posted
- 2024-05-16
- Last updated
- 2025-12-01
- Results posted
- 2025-12-01
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06415045. Inclusion in this directory is not an endorsement.